225 related articles for article (PubMed ID: 19196804)
1. Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia.
Lozano D; de Castro LF; Dapía S; Andrade-Zapata I; Manzarbeitia F; Alvarez-Arroyo MV; Gómez-Barrena E; Esbrit P
Endocrinology; 2009 May; 150(5):2027-35. PubMed ID: 19196804
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia.
Lozano D; Fernández-de-Castro L; Portal-Núñez S; López-Herradón A; Dapía S; Gómez-Barrena E; Esbrit P
Br J Pharmacol; 2011 Mar; 162(6):1424-38. PubMed ID: 21175568
[TBL] [Abstract][Full Text] [Related]
3. Role of the N- and C-terminal fragments of parathyroid-hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment.
de Castro LF; Lozano D; Dapía S; Portal-Núñez S; Caeiro JR; Gómez-Barrena E; Esbrit P
Tissue Eng Part A; 2010 Apr; 16(4):1157-68. PubMed ID: 19860552
[TBL] [Abstract][Full Text] [Related]
4. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
5. Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.
Rodríguez-de la Rosa L; López-Herradón A; Portal-Núñez S; Murillo-Cuesta S; Lozano D; Cediel R; Varela-Nieto I; Esbrit P
PLoS One; 2014; 9(2):e87536. PubMed ID: 24503961
[TBL] [Abstract][Full Text] [Related]
6. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro.
de Gortázar AR; Alonso V; Alvarez-Arroyo MV; Esbrit P
Calcif Tissue Int; 2006 Nov; 79(5):360-9. PubMed ID: 17120184
[TBL] [Abstract][Full Text] [Related]
7. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
McCauley LK; Koh AJ; Beecher CA; Cui Y; Decker JD; Franceschi RT
J Bone Miner Res; 1995 Aug; 10(8):1243-55. PubMed ID: 8585429
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34.
Miao D; He B; Jiang Y; Kobayashi T; Sorocéanu MA; Zhao J; Su H; Tong X; Amizuka N; Gupta A; Genant HK; Kronenberg HM; Goltzman D; Karaplis AC
J Clin Invest; 2005 Sep; 115(9):2402-11. PubMed ID: 16138191
[TBL] [Abstract][Full Text] [Related]
9. Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells.
Lozano D; Feito MJ; Portal-Núñez S; Lozano RM; Matesanz MC; Serrano MC; Vallet-Regí M; Portolés MT; Esbrit P
Acta Biomater; 2012 Jul; 8(7):2770-7. PubMed ID: 22487933
[TBL] [Abstract][Full Text] [Related]
10. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
12. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
Koh AJ; Beecher CA; Rosol TJ; McCauley LK
Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice.
Miao D; Li J; Xue Y; Su H; Karaplis AC; Goltzman D
Endocrinology; 2004 Aug; 145(8):3554-62. PubMed ID: 15090463
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney.
Ardura JA; Berruguete R; Rámila D; Alvarez-Arroyo MV; Esbrit P
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F415-25. PubMed ID: 18550647
[TBL] [Abstract][Full Text] [Related]
15. Regulation of parathyroid hormone/parathyroid hormone-related protein receptor expression by osteoblast-deposited extracellular matrix in a human osteoblast-like cell line.
Hausmann S; Law FM; Bonjour JP; Feyen J; Rizzoli R
J Cell Physiol; 1995 Oct; 165(1):164-71. PubMed ID: 7559797
[TBL] [Abstract][Full Text] [Related]
16. PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.
Maycas M; McAndrews KA; Sato AY; Pellegrini GG; Brown DM; Allen MR; Plotkin LI; Gortazar AR; Esbrit P; Bellido T
J Bone Miner Res; 2017 Mar; 32(3):486-497. PubMed ID: 27683064
[TBL] [Abstract][Full Text] [Related]
17. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
Hamada Y; Kitazawa S; Kitazawa R; Fujii H; Kasuga M; Fukagawa M
Bone; 2007 May; 40(5):1408-14. PubMed ID: 17251074
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone.
Faucheux C; Horton MA; Price JS
J Bone Miner Res; 2002 Mar; 17(3):455-64. PubMed ID: 11874237
[TBL] [Abstract][Full Text] [Related]
20. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development.
Amizuka N; Karaplis AC; Henderson JE; Warshawsky H; Lipman ML; Matsuki Y; Ejiri S; Tanaka M; Izumi N; Ozawa H; Goltzman D
Dev Biol; 1996 Apr; 175(1):166-76. PubMed ID: 8608863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
